geniposide has been researched along with Cognitive Decline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Chen, T; He, L; Li, Y; Liu, S; Zheng, M | 1 |
Gao, W; Li, L; Liu, Y; Wang, X; Zhang, D; Zhang, Z | 1 |
Li, L; Liu, Y; Wang, X; Zhang, D; Zhang, Z | 1 |
3 other study(ies) available for geniposide and Cognitive Decline
Article | Year |
---|---|
The protective effect of Geniposide on diabetic cognitive impairment through BTK/TLR4/NF-κB pathway.
Topics: Agammaglobulinaemia Tyrosine Kinase; Animals; Blood Glucose; Cell Line, Tumor; Cognitive Dysfunction; Diabetes Mellitus; Dose-Response Relationship, Drug; Humans; Iridoids; Male; Mice; Mice, Inbred ICR; NF-kappa B; Random Allocation; Signal Transduction; Streptozocin; Toll-Like Receptor 4; Treatment Outcome | 2020 |
Geniposide effectively reverses cognitive impairment and inhibits pathological cerebral damage by regulating the mTOR Signal pathway in APP∕PS1 mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Iridoids; Male; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Peptide Fragments; Plaque, Amyloid; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |
Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Autophagy; Behavior, Animal; Cognitive Dysfunction; Down-Regulation; Gene Expression Regulation; Humans; Iridoids; Mice; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid; Random Allocation; TOR Serine-Threonine Kinases | 2019 |